Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.

Ritzén EM, Lindgren AC, Hagenäs L, Marcus C, Müller J, Blichfeldt S.

J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:345-9. Review.

PMID:
10698600
2.

Body composition during GH treatment in Prader-Labhardt-Willi syndrome.

Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G.

J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:351-3.

PMID:
10698601
3.

Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome.

Davies PS, Evans S, Broomhead S, Clough H, Day JM, Laidlaw A, Barnes ND.

Arch Dis Child. 1998 May;78(5):474-6.

4.
5.

Body composition in Prader-Willi syndrome: assessment and effects of growth hormone administration.

Davies PS.

Acta Paediatr Suppl. 1999 Dec;88(433):105-8. Review.

PMID:
10626557
6.

Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group.

Lindgren AC, Hagenäs L, Müller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzén EM.

Acta Paediatr Suppl. 1997 Nov;423:60-2.

PMID:
9401542
7.
8.
9.

Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome.

Eiholzer U, Weber R, Stutz K, Steinert H.

Acta Paediatr Suppl. 1997 Nov;423:66-8.

PMID:
9401543
10.

Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.

Lindgren AC, Hagenäs L, Müller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzén EM.

Acta Paediatr. 1998 Jan;87(1):28-31.

PMID:
9510443
11.

Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.

Sipilä I, Sintonen H, Hietanen H, Apajasalo M, Alanne S, Viita AM, Leinonen E.

Acta Paediatr. 2010 Nov;99(11):1712-8. doi: 10.1111/j.1651-2227.2010.01904.x. Epub 2010 Jul 5.

PMID:
20545932
13.

Somatropin therapy in adults with Prader-Willi syndrome.

Höybye C, Thorén M.

Treat Endocrinol. 2004;3(3):153-60. Review.

PMID:
16026111
14.
15.
16.

Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.

Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Sep;69(3):443-51. doi: 10.1111/j.1365-2265.2008.03228.x. Epub 2008 Mar 18.

PMID:
18363884
17.
18.

Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.

Lin HY, Lin SP, Tsai LP, Chao MC, Chen MR, Chuang CK, Huang CY, Tsai FJ, Chou IC, Chiu PC, Huang CH, Yen JL, Lin JL, Kuo PL.

J Chin Med Assoc. 2008 Jun;71(6):305-9. doi: 10.1016/S1726-4901(08)70127-8.

19.

The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.

Meinhardt U, Christiansen JS, Farholt S, Lämmer C, Ostergaard JR, Schmidt F, Kappelgaard AM, Eiholzer U.

Horm Metab Res. 2013 Jul;45(7):532-6. doi: 10.1055/s-0033-1343449. Epub 2013 Apr 30.

PMID:
23632904
20.

Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.

Whitman B, Carrel A, Bekx T, Weber C, Allen D, Myers S.

J Pediatr Endocrinol Metab. 2004 Apr;17(4):591-600.

PMID:
15198290

Supplemental Content

Support Center